Skip Navigation

JNCI Journal of the National Cancer Institute 2001 93(8):579-580; doi:10.1093/jnci/93.8.579
© 2001 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by McCann, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McCann, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 93, No. 8, 579-580, April 18, 2001
© 2001 Oxford University Press

NEWS

Better Assays Needed for Hormone Receptor Status, Experts Say

Jean McCann

Some women who would benefit from hormonal therapy for breast cancer are not getting it because they have been found to be estrogen receptor and progesterone receptor negative when they are, in fact, at least weakly positive for both receptors.

"The testing has to be done right, and it’s not," said D. Craig Allred, M.D., of Baylor College of Medicine, Houston, a pathologist who has extensively studied the subject. At the San Antonio Breast Cancer Symposium, Allred decried the number of false negatives that he said were arising from . . . [Full Text of this Article]

Deny Few

What’s Behind It


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?